000963 华东医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额2,275,2563,929,2172,381,8533,169,7583,411,448
投资活动产生之现金流量净额(669,504)(1,750,552)(2,435,598)(1,986,683)(1,738,637)
筹资活动产生之现金流量净额(487,230)(1,393,361)(99,710)(767,453)(725,730)
汇率变动对现金及现金等价物的影响(5,787)5,946(9,775)7,112(21,445)
现金及现金等价物净增加/(减少)1,112,735791,249(163,230)422,734925,636
期初现金及现金等价物余额4,208,1603,416,9113,580,1413,157,4072,231,772
期末现金及现金等价物余额5,320,8954,208,1603,416,9113,580,1413,157,407